The Approval Process in Action

Source: The Life Sciences Report and Visual Capitalist (5/1/13)

What catalysts in the drug development process move biotech company stocks? The savvy investor must know what steps in the U.S. Food and Drug Administration's approval process can propel a stock up or down. From drug discovery to the much-anticipated PDUFA date, The Life Sciences Report and the Visual Capitalist have collaborated on an infographic that describes both the process and related catalysts.

For news on how catalysts affect specific stocks, read the updated Life Sciences Report Watchlist.

'Super Material' Stronger Than Steel, Harder Than Diamonds, More Conductive Than Copper
Source: Streetwise Reports (07/15/2025)

Jay Taylor and Bob Moriarty interview HydroGraph Clean Power Inc. (HG:CSE) Chief Executive officer, President, and Board Chair Kjirstin Breure as the company readies for what could be a "pivotal year" in a mostly unknown field that some say will change technology as much as silicon chips and transistors did in the 20th century.

Biotech Partnership to Revolutionize Diabetes Treatment
Source: Streetwise Reports (07/15/2025)

Sernova Biotherapeutics Inc. (SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA) announces a collaborative research agreement with Eledon Pharmaceuticals Inc. to assess Eledon's immunosuppressive drug in Sernova's ongoing trials of its cell pouch biohybrid organ for patients with Type 1 diabetes (T1D).

Portable Rapid Testing Kit Drives Development of 'Forever Chemical' Solution
Source: Streetwise Reports (07/15/2025)

BioLargo Inc. (BLGO:OTCQX) announced it has initiated "alpha testing" of a PFAS-detecting portable water test kit. Find out why one analyst says the stock is a Buy.

Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) launches virtual screening for older adults in NYC, backed by US$1M from CVS Health Foundation, as it scales AI tools and patient reach. Read more about how this initiative is helping expand access to care and driving growth in virtual health innovation.

Silver Explorer Uncovers High-Grade Silver Bonanza in BC
Source: Streetwise Reports (07/11/2025)

Silver47 Exploration Corp. (AGA:TSX.V; AAGAF:OTCQB) conducted a 5,008-sample survey at Adams Plateau, hit surface assays to 3,503 g/t Ag, and locked in a 5-year drill permit to drill silver-rich SEDEX targets. Read more as the company readies its first modern drilling on the 150 square kilometer property, with new geochemical data and prospector's found showings.